Quest Diagnostics 2024年第四季度调整后每股收益$2.23，超过预期的$2.19，销售额为$26.2亿，超过预期的$25.8亿

财报速递2025-01-30
Quest Diagnostics (NYSE:DGX)报告的季度每股收益为$2.23，超过分析师预期的$2.19，超出1.83%。这是相比去年同期每股收益$2.15增长了3.72%。公司报告的季度销售额为$26.2亿，超过分析师预期的$25.8亿，超出1.65%。相比去年同期销售额$22.9亿增长了14.55%。

以上内容来自Benzinga Earnings专栏，原文如下：

Quest Diagnostics (NYSE:DGX) reported quarterly earnings of $2.23 per share which beat the analyst consensus estimate of $2.19 by 1.83 percent. This is a 3.72 percent increase over earnings of $2.15 per share from the same period last year. The company reported quarterly sales of $2.62 billion which beat the analyst consensus estimate of $2.58 billion by 1.65 percent. This is a 14.55 percent increase over sales of $2.29 billion the same period last year.

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白
发表看法